DMPA-SC Contraception journal supplement articles

Related program: Sexual & Reproductive Health

A special supplement on DMPA-SC will be published in the November 2018 issue of the journal Contraception. The supplement will feature 13 articles which are now individually available online. These are authored by several different partner organizations and explore a range of topics including task-sharing, contraceptive continuation, cost and cost-effectiveness, acceptability and feasibility, storage and disposal, and private sector provision across six countries. A commentary authored by Dr. Ian Askew, Director of Reproductive and Research at the World Health Organization and Elisa Wells provides an overview of these research results and their implications.

For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.

Supplement articles

DMPA-SC: an emerging option to increase women's contraceptive choices (Askew)

Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda (Cover)

Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal (Di Giorgio)

Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda (Di Giorgio)

Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi (Burke)

An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa (Bertrand)

Women’s satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial (Burke)

Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: Findings from a prospective cohort study in Burkina Faso and Uganda (MacLachlan)

Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects (Liu)

Family planning provision in pharmacies and drug shops: an urgent prescription (Chin-Quee)

Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria’s private sector (Liu)

Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers (Hernandez)

Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study (Mwembo)

*DMPA-SC: Subcutaneous depot medroxyprogesterone acetate.
Sayana Press is a registered trademark of Pfizer Inc. Uniject is a trademark of BD.